STANLEY M MARKS M.D.
Prescription History 1477524924
Internal Medicine - Hematology & Oncology in Pittsburgh, PA
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for STANLEY M MARKS M.D., an active Hematology & Oncology specialist practicing in Pittsburgh, PA. Our medical registry currently tracks 17 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 550 documented patient claims. Among these therapy options, the most frequently utilized medication is Letrozole, which accounts for 86 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2023)Rx (2023) | Avg Cost per FillCost / Fill | Vs. Other PA PrescribersVs. PA Avg |
|---|---|---|---|
| Letrozole | 86 | $24.15▼ below PA avg | ▲ More than typical |
About Letrozole: This medication is used to treat certain types of breast cancer (such as hormone-receptor-positive breast cancer) in women after menopause. Show more ▾ Letrozole is also used to help prevent the cancer from returning. Some breast cancers are made to grow faster by a natural hormone called estrogen. Letrozole decreases the amount of estrogen the body makes and helps to slow or reverse the growth of these breast cancers. A triazole and benzonitrile derivative that is a selective non-steroidal aromatase inhibitor, similar to ANASTROZOLE. It is used in the treatment of metastatic or locally advanced breast cancer in postmenopausal women. In 2023, this provider wrote 86 Medicare prescriptions for Letrozole, about 1.9 times the volume of the typical Pennsylvania prescriber of this medication (46). Medicare paid an average of $24.15 per fill, versus $26.83 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 164 30-Day Fills standardized to 30-day supplies 4,897 Days of Medication total across all patients in 2023 | |||
| ImbruvicaIbrutinib | 53 | $12,943.18▼ below PA avg | ▲ More than typical |
About Imbruvica: This medication is used to treat certain cancers (such as mantle cell or marginal zone lymphoma, chronic lymphocytic leukemia/small lymphocytic lymphoma, Waldenstrom's macroglobulinemia). Show more ▾ Ibrutinib belongs to a class of drugs known as kinase inhibitors. It works by slowing or stopping the growth of cancer cells. Ibrutinib is also used to treat a certain problem that may occur after a stem cell transplant (chronic graft versus host disease). It works by weakening your body's defense system (immune system). In 2023, this provider wrote 53 Medicare prescriptions for Imbruvica, about 1.7 times the volume of the typical Pennsylvania prescriber of this medication (31). Medicare paid an average of $12,943.18 per fill, versus $14,546.74 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 53 30-Day Fills standardized to 30-day supplies 1,528 Days of Medication total across all patients in 2023 | |||
| IbrancePalbociclib | 49 | $13,417.99▼ below PA avg | ▲ More than typical |
About Ibrance: Palbociclib is used to treat a certain type of breast cancer. Show more ▾ It works by slowing or stopping the growth of cancer cells. In 2023, this provider wrote 49 Medicare prescriptions for Ibrance, about 1.8 times the volume of the typical Pennsylvania prescriber of this medication (28). Medicare paid an average of $13,417.99 per fill, versus $14,656.09 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 49 30-Day Fills standardized to 30-day supplies 1,372 Days of Medication total across all patients in 2023 | |||
| CalquenceAcalabrutinib Maleate | 42 | $11,615.26▼ below PA avg | ▲ More than typical |
About Calquence: This medication is used to treat certain types of cancer (such as mantle cell lymphoma, small lymphocytic lymphoma - SLL, chronic lymphocytic leukemia - CLL). Show more ▾ Acalabrutinib works by slowing or stopping the growth of cancer cells. It belongs to a class of drugs known as kinase inhibitors. In 2023, this provider wrote 42 Medicare prescriptions for Calquence, about 2 times the volume of the typical Pennsylvania prescriber of this medication (21). Medicare paid an average of $11,615.26 per fill, versus $14,167.73 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 42 30-Day Fills standardized to 30-day supplies 1,260 Days of Medication total across all patients in 2023 | |||
| Acyclovir | 36 | $13.49▼ below PA avg | ▲ More than typical |
About Acyclovir: Acyclovir is used to treat infections caused by certain types of viruses. Show more ▾ It treats cold sores around the mouth (caused by herpes simplex), shingles (caused by herpes zoster), and chickenpox. This medication is also used to treat outbreaks of genital herpes. In people with frequent outbreaks, acyclovir is used to help reduce the number of future episodes. Acyclovir is an antiviral drug. However, it is not a cure for these infections. The viruses that cause these infections continue to live in the body even between outbreaks. Acyclovir decreases the severity and length of these outbreaks. It helps the sores heal faster, keeps new sores from forming, and decreases pain/itching. This medication may also help reduce how long pain remains after the sores heal. In addition, in people with a weakened immune system, acyclovir can decrease the risk of the virus spreading to other parts of the body and causing serious infections. A GUANOSINE analog that acts as an antimetabolite. Viruses are especially susceptible. Used especially against herpes. In 2023, this provider wrote 36 Medicare prescriptions for Acyclovir, about 1.3 times the volume of the typical Pennsylvania prescriber of this medication (27). Medicare paid an average of $13.49 per fill, versus $26.32 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 38 30-Day Fills standardized to 30-day supplies 1,140 Days of Medication total across all patients in 2023 | |||
| Exemestane | 36 | $128.76▼ below PA avg | ▲ More than typical |
About Exemestane: This medication is used to treat certain types of breast cancer (such as hormone-receptor-positive breast cancer) in women after menopause. Show more ▾ Exemestane is also used to help prevent the cancer from returning. Some breast cancers are made to grow faster by a natural hormone called estrogen. Exemestane decreases the amount of estrogen the body makes and helps to slow or reverse the growth of these breast cancers. Exemestane is usually not used in women of childbearing age. In 2023, this provider wrote 36 Medicare prescriptions for Exemestane, about 1.4 times the volume of the typical Pennsylvania prescriber of this medication (26). Medicare paid an average of $128.76 per fill, versus $258.43 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 76 30-Day Fills standardized to 30-day supplies 2,280 Days of Medication total across all patients in 2023 | |||
| BrukinsaZanubrutinib | 36 | $6,825.68▼ below PA avg | ▲ More than typical |
About Brukinsa: This medication is used to treat certain cancers (mantle cell lymphoma, marginal zone lymphoma, Waldenstrom's macroglobulinemia). Show more ▾ Zanubrutinib belongs to a class of drugs known as kinase inhibitors. It works by slowing or stopping the growth of cancer cells. In 2023, this provider wrote 36 Medicare prescriptions for Brukinsa, about 1.9 times the volume of the typical Pennsylvania prescriber of this medication (19). Medicare paid an average of $6,825.68 per fill, versus $12,611.25 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 36 30-Day Fills standardized to 30-day supplies 1,077 Days of Medication total across all patients in 2023 | |||
| Potassium Chloride | 31 | $17.71▼ below PA avg | ▼ Less than typical |
About Potassium Chloride: This medication is a mineral supplement used to treat or prevent low amounts of potassium in the blood. Show more ▾ A normal level of potassium in the blood is important. Potassium helps your cells, kidneys, heart, muscles, and nerves work properly. Most people get enough potassium by eating a well-balanced diet. Some conditions that can lower your body's potassium level include severe prolonged diarrhea and vomiting, hormone problems such as hyperaldosteronism, or treatment with water pills/diuretics. A white crystal or crystalline powder used in BUFFERS; FERTILIZERS; and EXPLOSIVES. It can be used to replenish ELECTROLYTES and restore WATER-ELECTROLYTE BALANCE in treating HYPOKALEMIA. In 2023, this provider wrote 31 Medicare prescriptions for Potassium Chloride, about half the volume of the typical Pennsylvania prescriber of this medication (70). Medicare paid an average of $17.71 per fill, versus $30.86 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 42 30-Day Fills standardized to 30-day supplies 1,182 Days of Medication total across all patients in 2023 | |||
| Pantoprazole Sodium | 29 | $7.07▼ below PA avg | ▼ Less than typical |
About Pantoprazole Sodium: Pantoprazole is used to treat certain stomach and esophagus problems (such as acid reflux). Show more ▾ It works by decreasing the amount of acid your stomach makes. This medication relieves symptoms such as heartburn, difficulty swallowing, and cough. It helps heal acid damage to the stomach and esophagus, helps prevent ulcers, and may help prevent cancer of the esophagus. Pantoprazole belongs to a class of drugs known as proton pump inhibitors (PPIs). 2-pyridinylmethylsulfinylbenzimidazole proton pump inhibitor that is used in the treatment of GASTROESOPHAGEAL REFLUX and PEPTIC ULCER. In 2023, this provider wrote 29 Medicare prescriptions for Pantoprazole Sodium, about a third of the volume of the typical Pennsylvania prescriber of this medication (96). Medicare paid an average of $7.07 per fill, versus $16.43 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 29 30-Day Fills standardized to 30-day supplies 870 Days of Medication total across all patients in 2023 | |||
| Gabapentin | 28 | $10.20▼ below PA avg | ▼ Less than typical |
About Gabapentin: Gabapentin is used with other medications to prevent and control seizures. Show more ▾ It is also used to relieve nerve pain following shingles (a painful rash due to herpes zoster infection) in adults. Gabapentin is known as an anticonvulsant or antiepileptic drug. A cyclohexane-gamma-aminobutyric acid derivative that is used for the treatment of PARTIAL SEIZURES; NEURALGIA; and RESTLESS LEGS SYNDROME. In 2023, this provider wrote 28 Medicare prescriptions for Gabapentin, about a third of the volume of the typical Pennsylvania prescriber of this medication (97). Medicare paid an average of $10.20 per fill, versus $21.72 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 34 30-Day Fills standardized to 30-day supplies 1,020 Days of Medication total across all patients in 2023 | |||
| Tamoxifen Citrate | 28 | $37.15 | ≈ Typical |
About Tamoxifen Citrate: Tamoxifen is used to treat breast cancer. Show more ▾ It is also used to reduce the chances of breast cancer in high-risk patients. This medication can block the growth of breast cancer. It works by interfering with the effects of estrogen in the breast tissue. One of the SELECTIVE ESTROGEN RECEPTOR MODULATORS with tissue-specific activities. Tamoxifen acts as an anti-estrogen (inhibiting agent) in the mammary tissue, but as an estrogen (stimulating agent) in cholesterol metabolism, bone density, and cell proliferation in the ENDOMETRIUM. In 2023, this provider wrote 28 Medicare prescriptions for Tamoxifen Citrate, about 88% of the volume of the typical Pennsylvania prescriber of this medication (32). Medicare paid an average of $37.15 per fill, versus $32.51 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 54 30-Day Fills standardized to 30-day supplies 1,620 Days of Medication total across all patients in 2023 | |||
| Escitalopram Oxalate | 22 | $12.07▼ below PA avg | ▼ Less than typical |
About Escitalopram Oxalate: Escitalopram is used to treat depression and anxiety. Show more ▾ It works by helping to restore the balance of a certain natural substance (serotonin) in the brain. Escitalopram belongs to a class of drugs known as selective serotonin reuptake inhibitors (SSRI). It may improve your energy level and feelings of well-being and decrease nervousness. S-enantiomer of CITALOPRAM. Belongs to a class of drugs known as SELECTIVE SEROTONIN REUPTAKE INHIBITORS, used to treat depression and generalized anxiety disorder. In 2023, this provider wrote 22 Medicare prescriptions for Escitalopram Oxalate, about a third of the volume of the typical Pennsylvania prescriber of this medication (64). Medicare paid an average of $12.07 per fill, versus $17.79 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 28 30-Day Fills standardized to 30-day supplies 840 Days of Medication total across all patients in 2023 | |||
| VerzenioAbemaciclib | 21 | $13,963.20 | ≈ Typical |
About Verzenio: This medication is used to treat certain types of breast cancer. Show more ▾ Abemaciclib works by slowing or stopping the growth of cancer cells. It belongs to a class of drugs known as kinase inhibitors. In 2023, this provider wrote 21 Medicare prescriptions for Verzenio, about 1.2 times the volume of the typical Pennsylvania prescriber of this medication (17). Medicare paid an average of $13,963.20 per fill, versus $13,735.63 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 21 30-Day Fills standardized to 30-day supplies 588 Days of Medication total across all patients in 2023 | |||
| Anastrozole | 15 | $36.97 | ▼ Less than typical |
About Anastrozole: Anastrozole is used to treat breast cancer in women after menopause. Show more ▾ Some breast cancers are made to grow faster by a natural hormone called estrogen. Anastrozole decreases the amount of estrogen the body makes and helps to slow or reverse the growth of these breast cancers. A nitrile and triazole derivative that acts as a selective nonsteroidal aromatase inhibitor. It is used in the treatment of ESTROGEN NUCLEAR RECEPTOR-positive breast cancer in postmenopausal women. In 2023, this provider wrote 15 Medicare prescriptions for Anastrozole, about a quarter of the volume of the typical Pennsylvania prescriber of this medication (69). Medicare paid an average of $36.97 per fill, versus $27.38 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 39 30-Day Fills standardized to 30-day supplies 1,170 Days of Medication total across all patients in 2023 | |||
| VenclextaVenetoclax | 14 | $7,339.74▼ below PA avg | ▼ Less than typical |
About Venclexta: This medication is used to treat certain types of cancer (chronic lymphocytic leukemia-CLL, small lymphocytic lymphoma-SLL, acute myeloid leukemia-AML). Show more ▾ Venetoclax is a drug that works by helping to slow or stop the growth of cancer cells. In 2023, this provider wrote 14 Medicare prescriptions for Venclexta, about half the volume of the typical Pennsylvania prescriber of this medication (24). Medicare paid an average of $7,339.74 per fill, versus $8,816.25 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 14 30-Day Fills standardized to 30-day supplies 372 Days of Medication total across all patients in 2023 | |||
| Prednisone | 13 | $3.61▼ below PA avg | ▼ Less than typical |
About Prednisone: Prednisone is used to treat conditions such as arthritis, blood disorders, breathing problems, severe allergies, skin diseases, cancer, eye problems, and immune system disorders. Show more ▾ Prednisone belongs to a class of drugs known as corticosteroids. It decreases your immune system's response to various diseases to reduce symptoms such as swelling and allergic-type reactions. A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver. In 2023, this provider wrote 13 Medicare prescriptions for Prednisone, about a quarter of the volume of the typical Pennsylvania prescriber of this medication (48). Medicare paid an average of $3.61 per fill, versus $5.96 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 13 30-Day Fills standardized to 30-day supplies 303 Days of Medication total across all patients in 2023 | |||
| Zolpidem Tartrate | 11 | $0.47▼ below PA avg | ▼ Less than typical |
About Zolpidem Tartrate: Zolpidem is used for a short time to treat a certain sleep problem (insomnia) in adults. Show more ▾ If you have trouble falling asleep, it helps you fall asleep faster, so you can get a better night's rest. Zolpidem belongs to a class of drugs called sedative-hypnotics. It acts on your brain to produce a calming effect. An imidazopyridine derivative and short-acting GABA-A receptor agonist that is used for the treatment of INSOMNIA. In 2023, this provider wrote 11 Medicare prescriptions for Zolpidem Tartrate, about a quarter of the volume of the typical Pennsylvania prescriber of this medication (42). Medicare paid an average of $0.47 per fill, versus $7.20 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 11 30-Day Fills standardized to 30-day supplies 330 Days of Medication total across all patients in 2023 | |||
About this data. The prescription history for STANLEY M MARKS M.D. is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2023, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Hematology & Oncology prescribing approach at this Pittsburgh, PA practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average volume among PA prescribers of the same medication. Always confirm current medications and costs directly with the provider and your plan.
